If they continue to get very good results from the interim data, they won't need a BTD because it's well known that BP will either partner or purchase LL - they can't afford to sit on the sidelines for long.
Show me a drug that has as good or better results for NASH. It doesn't exist, which is why BP can't afford to ignore these results.
Market Data 
Markets 
AI
